Возраст домена | 22 года |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | 0 |
Страниц в Google | 221 |
Страниц в Яндексе | 38 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 5088650 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Pharmatest Services Ltd is a CRO offering preclinical efficacy services for the pharmaceutical industry. We offer both in vitro and in vivo models in the fields of oncology and skeletal diseases. In oncology we have special expertise in clinically predictive orthotopic and metastasis models, and especially models of bone metastasis.
assay development preclinical cro preclinical research services preclinical efficacy testing preclinical animal models preclinical contract research organization preclinical cro list preclinical oncology lab preclinical skeletal diseases lab cancer models preclinical cancer studies preclinical oncology studies skeletal disease models oncology research models animal models efficacy models preclinical cancer models bone analysis services model set-up radiopharmaceutical testing
Our services have been developed with just one goal in mind – to make your nonclinical drug development faster and more predictive. Our mission is to reduce the amount of drug candidates failing in clinical trials. Outsource your preclinical efficacy testing to Pharmatest and increase significantly the speed of your drug development with reduced costs. When you collaborate with Pharmatest you always get data you can trust. Our study reports can be used for filing regulatory approval from
UTF-8
153.99 КБ
2 500
98 448 симв.
83 239 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
gelifesciences.com | 1 | 6 |
0 | 105502 | 50870 | |
nsf.org | 1 | 7 |
0 | 120720 | 44842 | |
lucideon.com | 1 | n/a | 10 | 1006835 | 96996 | |
purepharma.com | 1 | 3 |
0 | 4588844 | Нет данных | |
labhut.com | 1 | 5 |
0 | 2459091 | Нет данных | |
pharma-test.de | 1 | 4 |
0 | 1885132 | Нет данных | |
weiss.info | 1 | 4 |
10 | 19527769 | Нет данных | |
vortexsg.com | 1 | 3 |
0 | 21103132 | Нет данных | |
pharmacomlabs.com | 1 | 1 |
20 | 1216541 | Нет данных | |
pharma-test-indo.com | 1 | 2 |
0 | 15717104 | Нет данных | |
Еще 8 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 5 Октября 2016 ) | |
Количество ссылок на сайт | 7 |
Количество доменов, которые ссылаются на сайт | 5 |
Количество найденных анкоров | 3 |
Исходящие (внешние) ссылки домена | 702 |
Количество доменов, на которые ссылается сайт | 37 |
Количество исходящих анкоров | 45 |
Внешние ссылки главной страницы ( 68 ) | |
asbmr.org/annual-meeting | ASBMR Annual Meeting |
link.springer.com/article/10.1007/s40610-019-0114-5 | Novel and Conventional Preclinical Models to Investigate Bone Metastasis |
hindawi.com/journals/jir/2019/4260987/ | Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model Without Affecting Normal... |
oxfordglobal.co.uk/immunooncology-congress/ | 4th Annual Advances in Immuno-oncology Congress |
eventbrite.com/e/preclinical-oncology-seminar-tickets-601786... | Oncology seminar registration |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=174 | Annual Meeting of AACR |
championsoncology.com/ | Champions Oncology |
taconic.com/ | Taconic Biosciences |
epo-berlin.com/ | EPO Berlin-Buch |
valirx.com/ | Valirx Plc |
biocom.org/s/events | Biocom seminar series |
idsplc.com/ids-isys-system/ | iSYS automated platform |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136#.... | Annual Meeting of AACR |
biocom.org/s/EventDetail?event=January-CRO-Event | educational seminar |
tumor-models-sf.com/ | Tumor models event |
clincancerres.aacrjournals.org/content/23/15/4335.long | latest scientific paper |
eventbrite.com/e/significance-of-bone-metastases-and-targeti... | this link |
info.taconic.com/new-humanized-mouse-model-of-tumor-growth-i... | scientific webinar |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=105&u... | Annual Meeting of AACR |
biocom.org/s/AboutUs | Biocom |
scienceexchange.com/products/marketplace | Science Exchange |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=61#.W... | EORTC-NCI-AACR |
fimm.fi/en | FIMM |
envigo.com/ | Envigo |
bruker.com/products/microtomography/in-vivo-micro-ct/skyscan... | SkyScan 1276 |
datecmedico.dk/en/products/item/ultrafocusdxr | Faxitron Ultrafocus DXA |
tumor-models.com/ | Tumor Models Boston 2015 |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=63#.V... | Annual Meeting of AACR |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=3cd5017e-c35... | section 27, poster board 22 |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=b096bfb6-3f9... | section 6, poster board 9 |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=b096bfb6-3f9... | section 6, poster board 28 |
ors.org/2016annualmeeting/ | Orthopaedic Research Society |
triconference.com/uploadedFiles/MMTC/Agenda/16/2016-MMTC-CAG... | Molecular Medicine Tri-conference |
tyopaikat.oikotie.fi/avoimet-tyopaikat/senior-scientist-turk... | Senior scientist position |
valirx.com/ | Valirx Plc |
1cqi8a4dpf4p8okqjp35hmi5.wpengine.netdna-cdn.com/wp-content/... | GeneICE technology |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=52&De... | AACR-NCI-EORTC |
eurostars-eureka.eu/ | Eurostars |
eurotransbio.eu/ | EuroTransBio |
eurostars-eureka.eu/project/id/9671 | Eurostars program |
eurotransbio.eu/index.php?index=156 | EuroTransBio program |
aurexel.com | Aurexel |
eaumadrid2015.uroweb.org/home | EAU Congress |
massbio.org/events/calendar/3000-massbio_annual_meeting_2015... | MassBio Annual meeting |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=25#.V... | AACR Annual Meeting |
ects-ibms2015.org/ | ECTS-IBMS-CIBD |
2015.oarsi.org/ | OARSI 2015 World Congress |
congress.utu.fi/scandlas2015/ | Scand-LAS Annual Meeting |
ddtwc.com/ | Drug Discovery and Therapy World Congress 2015 |
aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=52#.V... | AACR-NCI-EORTC: International Conference on Molecular Targets and Cancer Therapeutics |
triconference.com/Pre-Clinical-Oncology-Models/ | “Predictive Preclinical Models in Oncology” |
triconference.com/ | 22nd Annual Molecular Medicine Tri-Conference |
tumour-models.com/ | Tumour Models |
eurekanetwork.org/activities/eurostars | Eurostars programme |
worldpharmacongress.com/In-Vitro-Models-Cancer/ | Tumor Models |
virobayinc.com/ | Virobay Inc |
percuros.com | Percuros |
ncbi.nlm.nih.gov/pubmed/23682134 | paper that demonstrates efficacy of radium-223 dichloride also for bone metastases in breast cancer |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=0aa5ca18-90a... | abstract |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=d9be40dd-096... | abstract |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=a8d46b5e-630... | abstract |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=86e6a2b3-67c... | abstract |
abstractsonline.com/Plan/ViewAbstract.aspx?sKey=df39e6ba-222... | abstract |
sttinfo.fi/release?3&releaseId=3287118 | here |
sttinfo.fi/release?2&releaseId=3271809 | here |
sttinfo.fi/release?10&releaseId=619254 | here |
sttinfo.fi/release?11&releaseId=618166 | here |
linkedin.com/company/pharmatest-services-ltd | <img> |
Внутренние ссылки главной страницы ( 183 ) | |
/ | Home |
/company/ | COMPANY |
/services/ | services |
/references1/ | REFERENCES |
/rd-resources/ | R&D |
pharmatest.com/contact/ | Contact page |
/downloads/ | DOWNLOADS |
pharmatest.com/services/cancer-models/ | oncology |
/services/skeletal-disease-models/ | skeletal diseases |
pharmatest.com/company/video/ | Company video |
pharmatest.com/contact/events-2019/ | here |
pharmatest.com/references1/testimonials/ | a public testimonial |
pharmatest.com/services/why-choose-pharmatest/ | Why choose Pharmatest? |
pharmatest.com/news/pharmatest-has-established-subsidiary-us... | Pharmatest USA |
/index.php/news/radiotherapy-expertise-pharmatest/ | November 2, 2017 Pharmatest Services has successfully worked with radioactive compounds for almost a decade. Recent scientific p... |
pharmatest.com/news/pharmatest-launches-new-services-asbmr/ | Clinical Biomarkers |
pharmatest.com/news/pharmatest-launches-first-novel-humanize... | Humanized mouse models |
/index.php/news/pharmatest-attends-aacr-nci-eortc-and-sitc-2... | October 18, 2019 Pharmatest Services attends AACR-NCI-EORTC Conference in Boston, MA on October 26 –30 and SITC Annual Meeting 2... |
/index.php/download_file/view/372/345/ | Establishment of a novel prostate cancer bone metastasis model in humanized mice and early efficacy results of pembrolizumab |
/index.php/download_file/view/371/345/ | Establishment of primary tumor models of TNBC and ER+/HER2- breast cancer in humanized mice and validation of pembrolizumab effi... |
/index.php/download_file/view/373/345/ | Lack of immunotherapy efficacy in a syngeneic bone metastasis model of triple-negative breast cancer |
/index.php/download_file/view/375/345/ | Pitfalls in preclinical development of immunotherapies for ER+ breast cancer: estrogen as an immunomodulator potentially influen... |
/index.php/news/joy-wolfram-joins-board-pharmatest/ | August 20, 2019 Shareholders of Pharmatest have elected Dr. Joy Wolfram as a new board member. Dr. Wolfram is Assistant Professo... |
/index.php/news/pharmatest-attends-asbmr-annual-meeting-orla... | August 13, 2019 Pharmatest Services attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that wi... |
/index.php/download_file/view/363/343/ | of Novel Therapies. |
/index.php/download_file/view/365/343/ | Effect of Zoledronic Acid Treatment on Bone in +/G610C Mouse Model of Osteogenesis Imperfecta. |
/index.php/download_file/view/366/343/ | Prostate Cancer Bone Metastasis Model for Preclinical Evaluation of Radiopharmaceuticals. |
/index.php/download_file/view/368/343/ | Tartrate-Resistant Acid Phosphatase 5b in Rat Serum and Plasma. |
/index.php/download_file/view/367/343/ | Syngeneic Bone Metastasis Models for Testing Efficacy of Novel Therapies. |
/index.php/download_file/view/364/343/ | Young Adult Male and Female +/G610C Mice as an Animal Model of Osteogenesis Imperfecta. |
/index.php/news/new-scientific-articles-published-pharmatest... | May 31, 2019 Pharmatest Services has published an invited review article about preclinical bone metastasis models and a research... |
/index.php/news/pharmatest-attends-io-congress-and-arranges-... | May 10, 2019 Pharmatest attends the 4th Annual Advances in Immuno-oncology Congress arranged by Oxford Global Conferences in Lon... |
/index.php/news/pharmatest-attends-aacr-annual-meeting-atlan... | March 11, 2019 Pharmatest Services attends Annual Meeting of American Association for Cancer Research (AACR) held in Atlanta, Ge... |
/index.php/download_file/view/344/339/ | Poster ID 2007 |
/index.php/download_file/view/345/339/ | Poster ID 2161 |
/index.php/download_file/view/346/339/ | 2814 |
/index.php/download_file/view/351/339/ | 3936 |
/index.php/download_file/view/347/339/ | 4588 |
/index.php/download_file/view/348/339/ | 4614 |
/index.php/download_file/view/354/339/ | Poster ID 4616 |
/index.php/download_file/view/350/339/ | Poster ID 4850 |
/index.php/news/pharmatest-events-during-2019/ | January 11, 2019 Pharmatest has announced the list of events where Pharmatest representatives will attend during 2019. The first... |
/index.php/news/pharmatest-arranges-immuno-oncology-seminars... | December 5, 2018 Pharmatest Services arranges an immuno-oncology seminar series about humanized mouse models during 2019. The fi... |
/index.php/news/pharmatest-launches-new-services-asbmr/ | September 19, 2018 Pharmatest Services attends ASBMR Annual Meeting in Montreal, Canada on September 28 – October 1, 2018. In AS... |
/services/skeletal-disease-models/osteogenesis-imperfecta/ | osteogenesis imperfecta |
/services/clinical-biomarker-services/ | clinical bone marker measurements |
/index.php/news/pharmatest-attends-asbmr-annual-meeting-mont... | September 17, 2018 Pharmatest Services attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that... |
/index.php/news/pharmatest-20-year-celebration-symposium/ | May 24, 2018 June 15, 2018 marks the 20th anniversary of Pharmatest Services. We will be celebrating this important milestone by... |
/index.php/news/pharmatest-attends-aacr-annual-meeting-chica... | March 21, 2018 Pharmatest Services attends Annual Meeting of American Association for Cancer Research (AACR) held in Chicago, Il... |
/index.php/download_file/view/304/320/ | : Anti-PD-1 therapy reduces bone lesion growth in a novel syngeneic bladder cancer bone metastasis model. |
/index.php/download_file/view/313/320/ | Synergistic in vivo activity of the ATR inhibitor BAY 1895344 in combination with the targeted alpha therapy radium-223 dichlori... |
/index.php/download_file/view/311/320/ | : Phenotypic screening using AMIDA identifies different drug responses in breast and prostate cancer cell lines in an organotypi... |
/index.php/download_file/view/307/320/ | . |
/index.php/download_file/view/309/320/ | : PD-1/PD-L1 expression and tumor-infiltrating immune cells in triple-negative breast cancer: Characterization of preclinical pr... |
/index.php/download_file/view/306/320/ | : Castration-resistant prostate cancer bone metastasis model to assess new therapeutics. |
/index.php/download_file/view/308/320/ | : Drug sensitivity profiling of BT-474 breast cancer cell line for identification of novel therapies targeting HER2-positive bre... |
/index.php/download_file/view/310/320/ | . |
/index.php/news/another-successful-year-pharmatest/ | February 21, 2018 Year 2017 was again the most successful year in the history of Pharmatest, beating clearly the previous sales ... |
/index.php/news/pharmatest-events-during-2018/ | January 16, 2018 Pharmatest has announced the list of events where staff of Pharmatest will attend during 2018. The first events... |
pharmatest.com/contact/events-2018/ | here |
/index.php/news/pharmatest-credits-bruker-skyscan-1276-vivo-... | November 24, 2017 Bruker installed its first SkyScan 1276 High-Resolution and Fast In Vivo Desktop Micro-Computed Tomography (mi... |
pharmatest.com/services/radiotherapy-expertise/ | preclinical efficacy models |
/news/bayer-credits-high-quality-pharmatest-after-joint-publ... | long collaboration between Pharmatest and Bayer |
/index.php/news/pharmatest-attends-asbmr-annual-meeting-denv... | August 28, 2017 Pharmatest Services attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that wi... |
/index.php/download_file/view/217/303/ | Bone phenotype of human immune system engrafted mice. |
/index.php/download_file/view/220/303/ | PF708, a therapeutic equivalent and biosimilar candidate to Forteo (teriparatide), demonstrates nonclinical efficacy equivalence... |
/index.php/download_file/view/218/303/ | Effects of estrogen removal by ovariectomy on growth of human MCF-7 breast cancer cells in bone. |
/index.php/download_file/view/219/303/ | Suitability of various non-Invasive imaging techniques to analyze bone, muscle and fat tissues in ovariectomized mice. |
/index.php/news/educational-seminar-boston-highlights-signif... | August 24, 2017 Pharmatest Services LLC arranges an educational seminar titled “Significance of Bone Metastases and Targeting Tu... |
/index.php/news/pharmatest-has-established-subsidiary-usa/ | June 7, 2017 Pharmatest Services LLC is a US based CRO operating in Massachusetts, where it offers preclinical efficacy services... |
/index.php/news/pharmatest-launches-first-novel-humanized-mo... | May 16, 2017 Pharmatest Services Ltd has developed in collaboration with Taconic Biosciences a novel humanized mouse model of tu... |
pharmatest.com/services/cancer-models/humanized-mouse-models... | humanized mouse model |
pharmatest.com/files/3114/9189/5297/Pharmatest_poster_huNOG_... | late-breaking poster |
/index.php/news/pharmatest-attends-aacr-annual-meeting-washi... | March 13, 2017 Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in Washing... |
/index.php/download_file/view/202/295/ | Preclinical efficacy model to promote immunotherapy development for prostate cancer |
/index.php/download_file/view/204/295/ | New preclinical model for immuno-oncology: Combination of tumor, bone microenvironment and immune system |
/index.php/download_file/view/201/295/ | Immunodeficient mice differentially sensitize to estrogen and exhibit severe estrogen-related adverse effects in orthotopic brea... |
/index.php/download_file/view/199/295/ | Drug sensitivity profile of 5TGM1 murine multiple myeloma cell line emphasizes the translational potential of the syngeneic in v... |
/index.php/download_file/view/200/295/ | Selective drug sensitivity score (DSS) for indolent and aggressive prostate cancer cell lines |
/index.php/download_file/view/205/295/ | Additive benefits of radium-223 dichloride and bortezomib combination in a syngeneic 5TGM1 multiple myeloma mouse model |
/index.php/news/pharmatest-joins-biocom-and-science-exchange... | February 22, 2017 Pharmatest Services Ltd has joined two California-based organizations Biocom and Science Exchange. Biocom is t... |
/index.php/news/pharmatest-services-ltd-attends-tumor-models... | January 18, 2017 Pharmatest Services Ltd attends the Tumor Models conference in San Francisco, CA, on January 24 – 26. Pharmates... |
/index.php/news/pharmatest-services-ltd-attends-eortc-nci-aa... | November 22, 2016 Pharmatest Services Ltd attends the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Th... |
/index.php/download_file/view/195/280/ | Poster P065 |
/index.php/news/pharmatest-collaborates-envigo-preclinical-s... | October 12, 2016 Pharmatest has started a successful collaboration in preclinical studies with one of the world’s leading CROs. ... |
/index.php/news/pharmatest-services-ltd-invests-latest-bone-... | October 7, 2016 Pharmatest Services Ltd has purchased two new equipment for bone imaging with most advanced latest technologies,... |
/index.php/news/pharmatest-services-ltd-attends-asbmr-annual... | September 5, 2016 Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) t... |
/index.php/download_file/view/185/277/ | Poster FR0052 and SA0052 |
/index.php/download_file/view/189/277/ | Poster SA0318 |
/index.php/download_file/view/188/277/ | Poster SU0317 |
/index.php/news/pharmatest-opens-new-us-sales-offices/ | July 15, 2016 Pharmatest Services Ltd (Pharmatest) has opened new US sales offices in San Diego, CA, and Concord, MA near Boston... |
/index.php/news/pharmatest-services-ltd-attends-tumor-models... | July 5, 2016 Pharmatest Services Ltd attends 4th Annual Tumor Models conference in Boston, MA, on July 19 – 21. Pharmatest is sp... |
/index.php/news/pharmatest-releases-series-white-papers-2016... | May 30, 2016 Pharmatest Services Ltd releases three White Papers during 2016. The first White Paper was released before the AACR... |
/downloads/white-papers/ | Please download your copy of our White Paper here. |
/index.php/news/pharmatest-services-ltd-attends-aacr-annual-... | April 5, 2016 Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in New Orle... |
/index.php/download_file/view/176/267/ | section 18, poster board 15 |
/index.php/download_file/view/172/267/ | section 19, poster board 12 |
/index.php/download_file/view/175/267/ | section 29, poster board 16 |
/index.php/download_file/view/177/267/ | section 29, poster board 19 |
/index.php/download_file/view/174/267/ | section 29, poster board 23 |
/index.php/news/pharmatest-services-ltd-attends-ors-and-tri-... | March 4, 2016 Pharmatest Services Ltd attends the ORS Annual Meeting in Orlando, Florida, on March 5 – 8, and the TRI-CON event ... |
/index.php/download_file/view/170/262/ | “Differences in the Nature of Osteoarthritis between Surgically and Chemically Induced Rat Models” |
/index.php/download_file/view/169/262/ | “Novel luciferase labeling technique to improve imaging of orthotopic pancreatic cancer model” |
/index.php/news/list-events-pharmatest-attends-during-2016-h... | January 18, 2016 Pharmatest Services Ltd has finalized the list of events that the company will attend during 2016. The list inc... |
/!trash/scientific-events/ | Pharmatest events 2016 |
/index.php/news/pharmatest-hires-new-personnel-after-continu... | January 11, 2016 After several years of profitable growth Pharmatest will increase its staff amount by hiring four new employees... |
/index.php/news/pharmatest-services-ltd-partners-valirx-plc-... | October 28, 2015 Pharmatest Services Ltd and Valirx Plc have signed a 3-year collaboration agreement related to the proprietary ... |
/index.php/news/pharmatest-services-ltd-attends-aacr-nci-eor... | October 19, 2015 Pharmatest Services Ltd attends the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer The... |
/index.php/download_file/view/150/258/ | Radium-223 dichloride inhibits tumor growth and tumor-induced bone growth in osteoblastic prostate cancer models |
/index.php/download_file/view/151/258/ | VAL401 decreases tumor volume in a xenograft model of pancreatic cancer utilizing a novel improved luciferase labelling techniqu... |
/index.php/news/pharmatest-services-ltd-received-rd-funding-... | September 29, 2015 Together with its European partners Pharmatest Services Ltd has received two positive funding decisions for i... |
/index.php/news/pharmatest-services-ltd-approved-french-rese... | September 15, 2015 Pharmatest Services Ltd has been approved as an R&D performing organization by French tax authorities. The de... |
/index.php/news/pharmatest-services-ltd-attends-asbmr-annual... | September 3, 2015 Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) t... |
/index.php/download_file/view/148/255/ | Poster SA0350 |
/index.php/download_file/view/149/255/ | Poster SU0176 |
/index.php/download_file/view/146/255/ | Poster MO0212 |
/index.php/download_file/view/147/255/ | Poster MO0348 |
/index.php/news/pharmatest-services-ltd-participates-tumor-m... | July 9, 2015 Pharmatest Services Ltd attends Tumor Models event of Hanson Wade held in Boston, MA, USA, on July 21 – 23. Pharmat... |
/index.php/download_file/view/134/254/ | “Establishment of realistic patient-derived preclinical models for prostate cancer bone metastasis” |
/index.php/download_file/view/135/254/ | “Radium-223 dichloride exhibits dual mode-of-action inhibiting both tumor and tumor-induced bone growth in two osteoblastic pros... |
/index.php/download_file/view/133/254/ | “Novel luciferase labeling technique to improve imaging of orthotopic pancreatic cancer model” |
/index.php/news/pharmatest-attend-2015-oarsi-world-congress-... | April 28, 2015 Pharmatest will be attending the 2015 Osteoarthritis Research Society International (OARSI) World Congress in Sea... |
/index.php/download_file/view/130/253/ | “Changes in epiphyseal bone, subchondral bone plate and epiphyseal trabecular bone in surgically and chemically induced models o... |
/index.php/news/pharmatest-services-ltd-participates-cibd-ro... | April 24, 2015 Pharmatest Services Ltd attends Cancer-Induced Bone Disease (CIBD) meeting held in parallel with the ECTS-IBMS me... |
/index.php/download_file/view/127/252/ | Poster #115: |
/index.php/download_file/view/128/252/ | Poster #121: |
/index.php/download_file/view/129/252/ | Poster #139: |
/index.php/news/pharmatest-services-ltd-published-new-scient... | March 26, 2015 Pharmatest Services Ltd has published a new scientific review article “Importance of microenvironment in preclini... |
pharmatest.com/references1/list-publications/ | here |
/index.php/news/pharmatest-services-ltd-attends-aacr-annual-... | March 24, 2015 Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in Philade... |
/index.php/download_file/view/126/1/ | Bayer Pharma AG |
/index.php/download_file/view/123/1/ | Exelixis Inc |
/index.php/download_file/view/125/1/ | third presentation |
/index.php/news/list-events-pharmatest-attends-during-2015-h... | March 19, 2015 Pharmatest Services Ltd has updated the list of events that the company will attend during 2015. The list include... |
/index.php/news/pharmatest-services-ltd-attends-eau-congress... | March 16, 2015 Pharmatest Services Ltd attends the European Association of Urology (EAU) congress held in Madrid, Spain on March... |
/index.php/download_file/view/121/1/ | Presentation number 409 |
/index.php/download_file/view/122/1/ | Presentation number 787 |
/index.php/news/pharmatest-services-ltd-attends-tri-con-conf... | January 27, 2015 Pharmatest Services Ltd attends Cambridge Healthtech Institute’s third annual conference on “Predictive Preclin... |
/index.php/download_file/view/116/1/ | "Novel human organotypic 3D myoma based invasion assay applicable as a preclinical tool for cancer drug development" |
/index.php/download_file/view/117/1/ | "Towards a more efficient ensemble of predictive models for cancer drug development with special focus on metastatic bone diseas... |
/index.php/news/pharmatest-services-tumour-models-london-201... | November 28, 2014 December 2nd-4th, 2014 Pharmatest will be attending the Tumour Models meeting in London. The number one aim of... |
/index.php/news/pharmatest-services-ltd-attends-eortc-nci-aa... | October 27, 2014 Pharmatest Services Ltd attends 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics that... |
/index.php/download_file/view/107/243/ | Radium-223 dichloride - Efficacy and mode-of-action in a mouse model of prostate cancer bone metastasis |
/index.php/news/pharmatest-services-ltd-attends-asbmr-annual... | August 27, 2014 Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) tha... |
/index.php/download_file/view/86/236/ | Chondrogenic Differentiation Model Using KS483 Mouse Mesenchymal Progenitor Cell Line |
/index.php/download_file/view/87/236/ | Characterization of Monosodium Iodoacetate Induced Osteoarthritis in Rat Knee, Including Patellofemoral and Tibiofemoral Joints |
/index.php/download_file/view/88/236/ | Intra-Articular Treatment with Recombinant Human Bone Morphogenetic Protein 7 (rhBMP-7) Attenuates the Development of Post-Traum... |
/index.php/news/pharmatest-will-be-attending-13th-annual-wor... | May 21, 2014 Pharmatest will be attending the 13th Annual World Pharma Congress in Boston, MA, held on May 21-23, 2014. In the ... |
/index.php/download_file/view/84/223/ | Culturing Cancer Cells on Myoma Tissue: Development of a Novel Fully Human Organotypic 3D Invasion Model |
/index.php/news/pharmatest-attended-aacr-san-diego/ | May 2, 2014 Pharmatest Services Ltd had a very successful meeting in the Annual Meeting of American Association for Cancer Resea... |
/index.php/download_file/view/82/221/ | Combination of PI3K inhibitor BAY 1082439 with radium-223 is a promising treatment of cancer with bone metastases |
/index.php/download_file/view/80/221/ | Effects of Cabozantinib in the 5TGM1 murine multiple myeloma model |
/index.php/download_file/view/81/221/ | A new spectrum-selective cathepsin inhibitor, VBY-825, inhibits bone destruction in a syngeneic 5TGM1 multiple myeloma mouse mod... |
/index.php/news/pharmatest-attend-2014-oarsi-world-congress/ | April 23, 2014 Pharmatest will be attending the 2014 OARSI World Congress in Paris, France on April 24-27, 2014. Pharmatest att... |
/index.php/download_file/view/83/220/ | Download presentation here. |
/index.php/news/pharmatest-services-ltd-launches-new-product... | March 7, 2014 Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in San Dieg... |
/index.php/download_file/view/82/217/ | Bayer Pharma AG |
/index.php/download_file/view/80/217/ | Exelixis Inc |
/index.php/download_file/view/81/217/ | Virobay Inc. |
/!trash/references/ | Customer testimonials |
/index.php/news/pharmatest-attend-physiologically-relevant-c... | February 14, 2014 Pharmatest to attend High-Content Analysis and Physiologically-Relevant Cellular Models for Drug Discovery mee... |
/index.php/news/pharmatest-attend-meeting-predictive-preclin... | February 5, 2014 Pharmatest will be attending Predictive Preclinical Models in Oncology meeting on February 10-12, 2014 in Mosco... |
/index.php/news/pharmatest-services-ltd-attends-cibd-confere... | October 29, 2013 Pharmatest Services Ltd attends 13th international conference on cancer-induced bone disease (CIBD) held in Mia... |
/index.php/download_file/view/59/211/ | breast cancer |
/index.php/download_file/view/58/211/ | multiple myeloma |
/index.php/news/bayer-credits-high-quality-pharmatest-after-... | May 22, 2013 Pharmatest Services Ltd (Pharmatest) has been the preferred provider of Bayer Pharma AG (Bayer) since 2010. The res... |
/index.php/news/pharmatest-services-ltd-launches-new-preclin... | September 13, 2013 [Updated October 4, 2013] Turku, Finland -based CRO Pharmatest Services Ltd launches new fully validated prec... |
pharmatest.com/en/services/skeletal-disease-models/osteoarth... | four new preclinical OA models |
/index.php/download_file/view/54/205/ | poster presentation |
/index.php/news/pharmatest-present-new-data-oarsi-2013-meeti... | April 11, 2013 [Updated April 18, 2013] Pharmatest is proud to inform development of four new rat osteoarthritis models that wil... |
pharmatest.com/files/OARSI_2013_poster_112.pdf | “Degenerative changes in knee joints as determined by OARSI rat scoring system and osteoarthritis-related joint pain in surgical... |
/index.php/news/pharmatest-exhibit-and-present-new-data-aacr... | March 20, 2013 [Updated April 9, 2013] Pharmatest will be attending the key annual event in cancer research, AACR Annual Meetin... |
pharmatest.com/files/AACR_2013_poster_922.pdf | poster 922/20 on Sun, Apr 7, 1:00 - 5:00 PM |
pharmatest.com/files/AACR_2013_poster_LB-105.pdf | late-breaking poster LB-105/14 on Mon, Apr 8, 1:00 - 5:00 PM |
pharmatest.com/files/AACR_2013_poster_2080.pdf | poster 2080/3 on Mon, Apr 8, 1:00 - 5:00 PM |
pharmatest.com/files/AACR_2013_poster_2680.pdf | poster 2680/23 on Tue, Apr 9, 8:00 AM - 12:00 PM |
pharmatest.com/files/AACR_2013_poster_3842.pdf | poster 3842/13 on Tue, Apr 9, 1:00 - 5:00 PM |
/index.php/news/pharmatest-services-ltd-opens-us-sales-offic... | February 22, 2013 [Updated March 21, 2013] Turku, Finland-based Pharmatest Services Ltd (Pharmatest) has opened a new US sales o... |
pharmatest.com/en/company/contact | Contact page |
pharmatest.com/files/Boston%20office%20press%20release%20USA... | here |
/index.php/news/pharmatest-became-preferred-provider-valirx/ | October 16, 2012 The Turku-based company Pharmatest Services Ltd (Pharmatest) has signed a Master Service Agreement with the Lon... |
pharmatest.com/current-news | Last 12 months |
pharmatest.com/older-news | Older |
Domain Name: PHARMATEST.COM
Registry Domain ID: 86277857_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.joker.com
Registrar URL: http://www.joker.com
Updated Date: 2018-05-02T04:22:41Z
Creation Date: 2002-05-05T18:28:01Z
Registry Expiry Date: 2019-05-05T18:28:01Z
Registrar: CSL Computer Service Langenbach GmbH d/b/a joker.com
Registrar IANA ID: 113
Registrar Abuse Contact Email: abuse@joker.com
Registrar Abuse Contact Phone: +49.21186767447
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: CP-NS1.WMHOST.COM
Name Server: CP-NS2.WMHOST.COM
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-12-19T00:49:50Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
User-agent: *
Disallow: /config
Disallow: /controllers
Disallow: /elements
Disallow: /helpers
Disallow: /jobs
Disallow: /languages
Disallow: /libraries
Disallow: /mail
Disallow: /models
Disallow: /single_pages
Disallow: /tools
Disallow: /blocks/*.php$
Disallow: /blocks/*.xml$
Disallow: /concrete/*.php$
Disallow: /concrete/*.xml$
Disallow: /packages/*.php$
Disallow: /packages/*.xml$
Disallow: /updates/*.php$
Disallow: /updates/*.xml$
Disallow: /blocks/*.php$
Disallow: /blocks/*.xml$
Disallow: /concrete/*.php$
Disallow: /concrete/*.xml$
Disallow: /packages/*.php$
Disallow: /packages/*.xml$
Disallow: /updates/*.php$
Disallow: /updates/*.xml$
США - 192.185.109.121
CyrusOne LLC
Websitewelcome.com
HTTP/1.1 200 OK
Date: Thu, 14 Nov 2019 22:40:12 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Set-Cookie: CONCRETE5=mni60sq5u0qc5ho80mrurjgvd5; path=/; HttpOnly
Upgrade: h2,h2c
Connection: Upgrade
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"